Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
24.40
-1.17 (-4.58%)
Sep 23, 2026, 10:14 AM EDT - Market open
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.68 billion as of September 23, 2026. Its market cap has increased by 144.20% in one year.
Market Cap
1.68B
Enterprise Value
1.33B
1-Year Change
144.20%
Ranking
Category
Stock Price
$24.40
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.68B, an increase of 156.27%. That is a compound annual growth rate of 20.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 1.68B | 19.56% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 1.86B |
| Xencor | 1.86B |
| Vir Biotechnology | 1.84B |
| Stoke Therapeutics | 1.81B |
| Septerna | 1.80B |
| Hemab Therapeutics Holdings | 1.77B |
| Nanobiotix | 1.73B |
| Novavax | 1.72B |